Risperidone is a second-generation antipsychotic (SGA) medication used in the treatment of a number of mood and mental health conditions including schizophrenia and bipolar disorder.[L12885] It is one of the most widely used SGAs. [Paliperidone], another commonly used SGA, is the primary active metabolite of risperidone (i.e. 9-hydroxyrisperidone).[L12885] Schizophrenia and various mood disorders are thought to be caused by an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively. Risperidone is thought to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain.[L12885] Risperidone binds with a very high affinity to 5-HT2A receptors, approximately 10-20 fold greater than the drug's binding affinity to D2 receptors, and carries lesser activity at several off-targets which may responsible for some of its undesirable effects.[L12885]
Synonyms
Risperidone
Risperidone tartrate
Rispéridone
Risperidona
Risperidonum
Brand Names
Nu-risperidone
PMS-risperidone
Dom-risperidone
Risperidone - 2
Mylan-risperidone ODT
Perseris
Risperidone M-TAB
Ipg-risperidone
Taro-risperidone
Risperidone - 4
PMS-risperidone ODT
Mint-risperidon
Apo-risperidone
Risperdal Consta
Ratio-risperidone
PHL-risperidone ODT
Risperdal
Risperidone - 0.25
Q-risperidone
Uzedy
Mylan-risperidone
Mar-risperidone
Sandoz Risperidone
Risperidone
Dom-risperidone ODT
Jamp-risperidone
Truemed Group LLC
Risperdal M-tab
Risperidone - 1
Risperidone - 0.5
Risperdal Oral Solution
Act Risperidone
Risperidone - 3
Risperidone Tablets
Riva-risperidone
Teva-risperidone
Ag-risperidone
Okedi
Ava-risperidone
Pro-risperidone
Rykindo extended-release microspheres
PHL-risperidone
Ran-risperidone
Indication
Risperidone is indicated for the treatment of schizophrenia [L12885,L44692,L46297] and irritability associated with autistic disorder.[L12885] It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.[L12885,L44692] Risperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.[L12906] Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.[A177226]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
